Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012370-12Phase 4Active
Phase 4, open-label, single-arm trial of ertapenem in burn injury and Early infection, sponsored by CHU de Nantes. Primary endpoints: Total serum ertapenem concentrations at steady state, Total urinary ertapenem concentrations and 2 more. Started May 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012370-12.